Ignite Creation Date:
2024-05-06 @ 8:22 AM
Last Modification Date:
2024-10-26 @ 11:59 AM
Study NCT ID:
NCT02729961
Status:
WITHDRAWN
Last Update Posted:
2019-10-10
First Post:
2016-03-29
Brief Title:
Ceritinib With Brentuximab Vedotin in Treating Patients With ALK-Positive Anaplastic Large Cell Lymphoma
Sponsor:
Organization:
University of Washington